Haloperidol

Revision as of 21:54, 1 June 2015 by Ajgausepohl (talk | contribs) (Created page with "==General== *Type: Typical antipsychotic *Dosage Forms: PO, IM, IV *Common Trade Names: Haldol ==Adult Dosing== *Acute Agitation: *Psychosis: **0.5-2mg PO divided BID-TID, s...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

General

  • Type: Typical antipsychotic
  • Dosage Forms: PO, IM, IV
  • Common Trade Names: Haldol

Adult Dosing

  • Acute Agitation:
  • Psychosis:
    • 0.5-2mg PO divided BID-TID, slowly titrate q7days to effect with Max 100mg/day
  • Tourette Syndrome:
    • 0.5-2mg PO divided BID-TID, slowly titrate q7days to effect with Max 100mg/day
  • Agitation
    • 0.5-10mg PO q1-4hrs, Max 100mg/day

Pediatric Dosing

  • Acute Agitation:
  • Psychosis:
    • 3-12yo - 0.05-0.15mg/kg/day PO divided BID-TID, slowly titrate q7days to effect with Max 0.15mg/kg/day
    • >12 - 0.5mg-2mg PO divided BID-TID, slowly titrate q7days to effect with Max 100mg/day
  • Tourette Syndrome:
    • 3-12yo - 0.05-0.075mg/kg/day PO divided BID-TID, slowly titrate q7days to effect with Max 0.15mg/kg/day
    • >12 - 0.5mg-5mg PO divided BID-TID, slowly titrate q7days to effect with Max 100mg/day
  • Behavioral Disorders:
    • 3-12yo - 0.05-0.075mg/kg/day PO divided BID-TID, slowly titrate q7days to effect with Max 0.15mg/kg/day
    • >12 - 0.5mg-5mg PO divided BID-TID, slowly titrate q7days to effect with Max 100mg/day
  • Agitation:
    • 3-12yo - 0.01-0.03mg/kg/day PO divided BID-TID, slowly titrate q7days to effect with Max 0.15mg/kg/day
    • >12 - 0.5mg-10mg PO divided BID-TID, Max 100mg/day

Special Populations

  • Pregnancy Rating: C
  • Lactation risk: unknown, likely L4
  • Renal Dosing
    • Adult - none
    • Pediatric - none
  • Hepatic Dosing
    • Adult - Hepatic impairment
    • Pediatric - Hepatic impairment

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:
  • Mechanism of Action:

Comments

See Also

References